Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13760-018-1022-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Higher Prevalence of Common Neurological Soft Signs in Essential Tremor With Midline Distribution: A Multicenter Cohort Study.
J Clin Neurol
March 2025
Department of Geriatric Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Background And Purpose: Essential tremor with a midline distribution (Mid-ET) may represent a distinct subtype of essential tremor (ET) that primarily affects midline structures, often indicating advanced disease stage and increased severity. Recent studies have highlighted the complexity of Mid-ET, but research on neurological soft signs (NSS) in Mid-ET remains insufficient.
Methods: The patients with ET included in this cross-sectional study were divided into two subgroups based on whether or not the ET had a midline distribution: Mid-ET and No-Mid-ET.
Genetic Etiology Influences the Low-Frequency Components of Globus Pallidus Internus Electrophysiology in Dystonia.
Eur J Neurol
March 2025
Movement Disorders Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Background: Elevated low-frequency activity (4-12 Hz) within the globus pallidus internus (GPi) has been consistently associated with dystonia. However, the impacts of the genetic etiology of dystonia on low-frequency GPi activity remain unclear; yet it holds importance for adaptive deep brain stimulation (DBS) treatment.
Methods: We compared the properties of GPi electrophysiology acquired from 70 microelectrode recordings (MER) trajectories of DYT-GNAL, DYT-KMT2B, DYT-SGCE, DYT-THAP1, DYT-TOR1A, DYT-VPS16, and idiopathic dystonia (iDYT) patients who underwent GPi-DBS surgery across standard frequency bands.
Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey.
Brain Behav
March 2025
Department of Neurology, Ankara University School of Medicine, Ankara, Turkey.
Background: Understanding real-world experiences is crucial in determining the potential gaps in patient-centered healthcare in dystonia. We explored the challenges of people with dystonia (PwD) at the stages of diagnosis and botulinum neurotoxin (BoNT) treatment.
Methods: A multicenter survey was conducted face-to-face across seven university hospitals in Turkey.
Duloxetine-associated parkinsonism in a patient with subclinical parkinson's disease: a case report.
Neurol Sci
March 2025
Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Background: Duloxetine is a serotonin-norepinephrine reuptake inhibitor commonly used to treat depression and neuropathic pain. Duloxetine-associated parkinsonism has been previously reported in only two cases with psychiatric disorders. We present the first case where duloxetine unmasked motor manifestations of subclinical Parkinson's disease.
View Article and Find Full Text PDFClinical Reasoning: Juvenile-Onset Dopa-Responsive Dystonia-Until It Isn't.
Neurology
March 2025
James J. and Joan A. Gardner Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, OH.
Dopa-responsive dystonia (DRD) encompasses a broad spectrum of phenotypically diverse conditions, offering unique diagnostic challenges. We describe the case of a 24-year-old woman with dystonic gait and jerky position-sensitive limb tremor that initially responded exquisitely well to low-dose levodopa, suggesting DRD. Two years later, she developed parkinsonian features, ultimately leading to a diagnostic reclassification.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!